🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sergey Afanasyev

Institute of Evolutionary Physiology and Biochemistry

ORCID: 0000-0002-8393-820X
Immunology and MicrobiologyAgricultural and Biological SciencesEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.

60 citations

Sergey Afanasyev, Álvaro Fernández-Montero, Yang Ding, Shota Watanabe, Fumio Takizawa +7 more